Children are susceptible to infection with the novel coronavirus SARS-CoV-2. In this time of
uncertainty, this review attempts to compile information that may be helpful to pediatric …

This systematic review and meta‐analysis aimed to evaluate the efficacy of vigabatrin (VGB)
in treating infantile epileptic spasms syndrome (IESS). Databases of PubMed, Embase, Web …

Background Infantile spasms syndrome (IS) is a type of epilepsy affecting 1.6 to 4.5 per
10,000 children in the first year of life, often with severe lifelong neurodevelopmental …

Objective To compare the effectiveness of initial treatment for infantile spasms. Methods The
National Infantile Spasms Consortium prospectively followed up children with new-onset …

Objective To compare the effectiveness and cost‐effectiveness of adrenocorticotropic
hormone (ACTH) and oral steroids as first‐line treatment for infantile spasm resolution, we …

Background Infantile epileptic spasms syndrome (IESS) is the most common type of severe
epilepsy in infants. However, etiological frequency and optimized therapy, particularly …

Background This article explores the role of initial treatment on control of spasms and other
epilepsies at four years in children previously treated for West syndrome. Methods The Sri …

Introduction Infantile spasm (IS) is an epileptic syndrome with typical onset within the first 2
years of life. This condition might be caused by several etiologies. IS is associated with …

Justification West syndrome is one of the commonest causes of epilepsy in infants and
young children and is a significant contributor to neurodevelopmental morbidity. Multiple …

Over the last several decades, significant progress has been made in the discovery of
appropriate therapy in the management of infantile spasms (IS). Based on several well …